Formic Acid → HCID 178421863, compound
Reaction equation
[CH:1]1([N:4]2[CH2:12][C:11]3[C:6](=[CH:7][CH:8]=[C:9]([C:13]4[N:14]=[N:15][N:16]([C:19]5[C:20](F)=[N:21][CH:22]=[CH:23][CH:24]=5)[C:17]=4[CH3:18])[CH:10]=3)[C:5]2=[O:26])[CH2:3][CH2:2]1.C(O)=[O:28]>>[CH:1]1([N:4]2[CH2:12][C:11]3[C:6](=[CH:7][CH:8]=[C:9]([C:13]4[N:14]=[N:15][N:16]([C:19]5[C:20]([OH:28])=[N:21][CH:22]=[CH:23][CH:24]=5)[C:17]=4[CH3:18])[CH:10]=3)[C:5]2=[O:26])[CH2:3][CH2:2]1Participants
3
Procedure
180 mg of 4-(2-cyclopropyl-1-oxo-isoindoline-5-yl)-1-(2-fluoropyridine-3-yl)-5-methyl-1H-[1,2,3]triazole obtained in Example 49 was dissolved in 10 ml of formic acid, and the mixture was stirred for 5 hours. After cooling down to room temperature, the residues obtained by distilling out the solvents under reduced pressure were purified by silicagel column chromatography (chloroform:methanol=90:10) to obtain 112 mg of the above compound as a white solid.
Workup
- customthe residues obtained
- distillationby distilling out the solvents under reduced pressure
- customwere purified by silicagel column chromatography (chloroform:methanol=90:10)
Sources & evidence
- ORD record
- ord-c01d5b392f684645a180167cdbaf15ac
- Source dataset
- uspto-grants-2011_03
- Patent number
- US07902369B2
Reaction notes
Loading…